A new study uses large-scale genetic approach to uncover human genes controlling HIV infection.
With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.
Machine, Meet Stem Cells
New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.
Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease